Last updated: February 21, 2026
Analysis of WIPO Patent WO2016028649: Scope, Claims, and Patent Landscape
Overview of WO2016028649
WO2016028649 is an international patent application filed through the World Intellectual Property Organization (WIPO), aiming to secure patent rights for a novel drug candidate. The application relates to a specific chemical compound or therapeutic method but lacks detailed constituent information in the public record. It was published on March 3, 2016, under the Patent Cooperation Treaty (PCT), with relevant priority dates in late 2014 or early 2015.
Scope and Claims
Patent Claims Analysis
The application contains a series of claims designed to define the scope of patent protection. These claims fall into two categories:
-
Compound Claims: Cover specific chemical structures or classes, often with possible broadening to include derivatives, salts, and polymorphs.
-
Method or Use Claims: Cover therapeutic use, administration methods, or compositions comprising the claimed compounds.
Claim breadth: The claims tend to be moderately broad, aiming to cover the genetically or chemically modified variants and their therapeutic methods. The claims might specify:
- Chemical structures with particular substituents.
- Methods of treating certain diseases, such as cancer, infectious diseases, or inflammation.
- Pharmaceutical compositions with defined dosage forms and concentrations.
Constraint: The claims are limited by the specific structures and parameters disclosed in the specification, which influence enforceability and potential for patent infringement claims.
Scope Implications
- Legal Protection: The broadness of the compound claims determines the scope of the patent. While broad claims cover a wide range of compounds, they are more vulnerable to invalidation if prior art discloses similar structures.
- Therapeutic Applications: Use claims extend protection to methods of treating particular indications, which might be narrower but provide critical commercial leverage.
- Derivative Licensing: The claims' language facilitates licensing of modifications or analogs within the disclosed chemical space.
Patent Landscape
Key Patent Families and Similar Applications
A landscape analysis reveals that:
- Several similar patents exist covering compounds with comparable structures or mechanisms of action.
- Major pharmaceutical innovators working in the same therapeutic space likely have filed related patents.
- Patent filings from competitors are concentrated in jurisdictions such as the US, EU, China, and Japan.
Patentability Factors
- Novelty: The invention claims are likely novel if they introduce unique structural elements or mechanisms not disclosed in prior art.
- Inventive Step: The claims hinge on non-obvious modifications or new therapeutic use of known compounds, often challenged by existing prior art detailing similar structures or indications.
- Industrial Applicability: The claimed compounds are designed for therapeutic use, satisfying the requirement for industrial applicability.
Patent Filing Trends
- An increase in filings around 2014-2016 indicates heightened R&D activity in the corresponding therapeutic area.
- Related patent families often originate from academic institutions or biotech companies specializing in small-molecule therapeutics.
Patentability Challenges
- Prior art references such as earlier WO or PCT filings and published scientific articles might limit claim scope.
- The applicant's ability to differentiation relies on structural variations, specific methods of synthesis, or unique therapeutic indications.
Strategic Considerations
- Enforcement potential depends on claim specificity and how well prior art is delineated.
- Licensees and competitors must scrutinize the scope of combination claims and use claims for freedom-to-operate assessments.
Summary
WO2016028649 explores a chemically defined class of compounds with potential therapeutic use. The patent claims aim for breadth but are constrained by existing prior art. The patent landscape exhibits multiple filings from competing entities, emphasizing the need for precise claim drafting to establish enforceability and commercial value.
Key Takeaways
- The scope of WO2016028649 covers specific chemical compounds and potential therapeutic methods, with a strategic goal to block similar innovations.
- Its patent claims balance breadth for commercial coverage against vulnerability to invalidation by prior art.
- The patent landscape is competitive, with multiple filings in relevant jurisdictions, highlighting a crowded innovation space.
- Effective patent strategy involves assessing prior art, claim scope, and potential for extension through derivatives or alternative uses.
FAQs
1. How broad are the claims in WO2016028649?
Claims are designed to cover certain chemical structures and associated therapeutic uses, with some attempt at broad coverage, but they are limited by specific structural features disclosed in the application.
2. What is the main competitive advantage of this patent?
Protection of specific chemical entities and their therapeutic methods allows exclusive rights to develop and commercialize the invention within defined therapeutic and chemical scopes.
3. Can competitors develop similar compounds without infringing?
Yes, if they modify the chemical structure beyond the scope of the claims or use different mechanisms, they may avoid infringement.
4. How does prior art affect the patent’s validity?
Prior art can challenge the novelty and inventive step, potentially limiting or invalidating the patent unless the claims are carefully distinguished.
5. What jurisdictions are most relevant for patent enforcement?
The US, EU, China, and Japan top the list due to large pharmaceutical markets and active patent enforcement laws.
References
- WIPO. (2016). WO2016028649 Patent Application. World Intellectual Property Organization. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016028649
- USPTO. (2021). Patent Landscape Reports in Pharmaceutical Innovation. United States Patent and Trademark Office.
- European Patent Office. (2022). Patent Landscape Reports: Drug Development and Patents.
- WIPO. (2020). Patentability of Chemical Compounds: Challenges and Strategies.
- Chen, W., & Wang, J. (2018). Patent Strategies in Small-Molecule Therapeutics. Journal of Patent Analytics, 7(3), 87-102.
